Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Status:	Active, not recruiting
Conditions:	Cancer, Cancer, Endocrine, Thyroid Cancer
Therapuetic Areas:	Endocrinology, Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	2/28/2019
Start Date:	June 2013
End Date:	June 2020

A Phase II Study of Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam
radiation therapy, has on the patient and their thyroid cancer where surgery is not an option
or where despite surgery, the disease is still present.

Inclusion Criteria:

- Pathologically confirmed diagnosis of non-anaplastic non-medullary thyroid cancer that
is either grossly recurrent after surgery or unresectable with or without metastatic
disease.

- Age ≥18 years

- Karnofsky performance status ≥70%

- Men and women of childbearing potential must be willing to consent to using effective
contraception while on treatment and for at least 3 months after treatment.

- Patients must have ability to understand and the willingness to sign a written
informed consent document.

Exclusion Criteria:

- Women who are pregnant or lactating

- Inability to comply with study and/or follow-up procedures

We found this trial at

sites

Memorial Sloan Kettering Cancer Center

1275 York Ave
New York, New York 10021

(212) 639-2000